These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 409711)

  • 21. beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction.
    Sullivan JM; Adams DF; Hollenberg NK
    Circ Res; 1976 Oct; 39(4):532-6. PubMed ID: 963837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of an angiotensin II antagonist on autoregulation in the isolated dog kidney.
    Kaloyanides GJ; DiBona GF
    Am J Physiol; 1976 Apr; 230(4):1078-83. PubMed ID: 1267003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoregulation of renal blood flow in the puppy.
    Jose PA; Slotkoff LM; Montgomery S; Calcagno PL; Eisner G
    Am J Physiol; 1975 Oct; 229(4):983-8. PubMed ID: 1190343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II inhibition on blood pressure and renal hemodynamics in pregnant rats.
    Baylis C; Collins RC
    Am J Physiol; 1986 Feb; 250(2 Pt 2):F308-14. PubMed ID: 3511733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of angiotensinogenic hypertension in man using 1-sar-8-ala-angiotensin II (Saralasin, P-113).
    Streeten DH; Freiberg JM; Anderson GH; Dalakos TG
    Circ Res; 1975 Jun; 36(6 Suppl 1):125-32. PubMed ID: 1132074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graded effects of saralasin on prostaglandin E, plasma renin activity and renal blood flow in anaesthetized dogs.
    Wong PC; Zimmerman BG
    Clin Exp Pharmacol Physiol; 1983; 10(3):211-8. PubMed ID: 6354528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of intrarenal angiotensin II in the hemodynamic response to unilateral obstructive uropathy.
    Moody TE; Vaughan ED; Wyker AT; Gillenwater JY
    Invest Urol; 1977 Mar; 14(5):390-7. PubMed ID: 845004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II dependency of vascular resistance in the untouched kidney of renal hypertensive rats.
    Schwietzer G
    Nephron; 1980; 26(4):195-9. PubMed ID: 7432581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin blockade in studies of the feedback control of renin release in rats and rabbits.
    Stokes GS; Oates HF; Weber MA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():33s-36s. PubMed ID: 1077786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of altered sodium balance and adrenergic blockade on renin release induced in rats by angiotensin antagonism.
    Keeton TK; Pettinger WA; Campbell WB
    Circ Res; 1976 Jun; 38(6):531-9. PubMed ID: 1269103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms producing tachycardia in conscious baboons during environmental heat stress.
    Gorman AJ; Proppe DW
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Feb; 56(2):441-6. PubMed ID: 6706755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of the systemic and renal vascular actions of angiotensisn II with the 1-sar, 8-ala analogue in the rat.
    Ishikawa I; Hollenberg NK
    Life Sci; 1975 Jul; 17(1):121-9. PubMed ID: 1143005
    [No Abstract]   [Full Text] [Related]  

  • 33. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of renal nerve stimulation, renal blood flow and adrenergic blockade on plasma renin activity in the cat.
    Coote JH; Johns EJ; Macleod VH; Singer B
    J Physiol; 1972 Oct; 226(1):15-36. PubMed ID: 4404297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of angiotensin antagonists.
    Pettinger WA; Mitchell HC
    Fed Proc; 1976 Nov; 35(13):2521-5. PubMed ID: 976494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
    Streeten DH; Anderson GH; Freiberg JM; Dalakos TG
    N Engl J Med; 1975 Mar; 292(13):657-62. PubMed ID: 235090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between the renin-angiotensin and beta adrenergic nervous systems in drinking and pressor responses after renal artery constriction.
    Atkinson J; Lüthi P; Péra-Bally R; Peters-Haefeli L
    J Pharmacol Exp Ther; 1982 May; 221(2):453-60. PubMed ID: 6281416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
    Pettinger WA; Keeton K
    J Clin Invest; 1975 Feb; 55(2):236-43. PubMed ID: 236325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine blood flow and uterine renin secretion.
    Ferris TF; Stein JH; Kauffman J
    J Clin Invest; 1972 Nov; 51(11):2827-33. PubMed ID: 4342956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin-angiotensin-aldosterone system in experimental renal hypertension in the rabbit.
    Lohmeier TE; Davis JO
    Am J Physiol; 1976 Feb; 230(2):311-8. PubMed ID: 1259009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.